Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2017

View Archived Issues

AptaTargets raises funds to advance ApTOLL for acute ischemic stroke

Meaningful pain reduction seen with capsaicin formulation CNTX-4975 in Morton's neuroma

miR-21 a biomarker of visceral leishmaniasis vaccine immunogenicity

Corbin Therapeutics and Proteorex Therapeutics enter research and development collaboration

CHMP recommends approval of Insulin lispro Sanofi

GSK-2269557 effects evaluated in phase II COPD trial

Phase II results for cibinetide in patients with sarcoidosis-associated SNFL and neuropathic pain

Safety review committee approves continuation of Betalutin study

Erx Pharmaceuticals synthesizes novel celastrol derivatives

EMA validates application seeking expanded approval of Sprycel

EMA committee backs approval of Zykadia for first-line use in ALK+ NSCLC

Additional tolerability proof-of-concept data to be presented for KarXT

EMA accepts for review MAA for adalimumab biosimilar, FKB-327

Chiesi's triple combination for the treatment of COPD receives positive opinion from EMA

Topline phase III data from active-comparator ARCH study of Evenity

MSD submits application in Japan for approval of combination drug for type 2 diabetes

Articular cartilage product granted positive opinion from CHMP for European approval

Trillium Therapeutics patents compounds for CNS disorders

Midatech selects preferred candidate for the treatment of glioblastoma

AstraZeneca enrolling patients in phase I trial of AZD-9898

Recordati to acquire European rights to AstraZeneca's metoprolol-based treatments

Cardioxane receives positive CHMP opinion in Europe

MAX BioPharma discovers new hedgehog and/or CTGF inhibitors

Heptares Therapeutics presents novel CGRP receptor antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...